AKR1C2
Aldo-keto reductase family 1 member C2
Also known as: AK1C2_HUMAN, BABP, DD, DD2, DDH2, HAKRD, MCDR2, TDD
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P52895
- Gene
- AKR1C2
- Ensembl
- ENSG00000151632
- Chromosome
- 10
- Canonical length
- 323 aa
- Protein class
- Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Nucleoli fibrillar center,Endoplasmic reticulum,Cytosol
OverviewNCBI Gene
This gene encodes a member of the aldo/keto reductase superfamily, which consists of more than 40 known enzymes and proteins. These enzymes catalyze the conversion of aldehydes and ketones to their corresponding alcohols using NADH and/or NADPH as cofactors. The enzymes display overlapping but distinct substrate specificity. This enzyme binds bile acid with high affinity, and shows minimal 3-alpha-hydroxysteroid dehydrogenase activity. This gene shares high sequence identity with three other gene members and is clustered with those three genes at chromosome 10p15-p14. Three transcript variants encoding two different isoforms have been found for this gene. [provided by RefSeq, Dec 2011]
Canonical amino-acid sequenceUniProt
323 residues, UniProt reviewed canonical sequence.
>P52895|AKR1C2
1 MDSKYQCVKL NDGHFMPVLG FGTYAPAEVP KSKALEAVKL AIEAGFHHID SAHVYNNEEQ
61 VGLAIRSKIA DGSVKREDIF YTSKLWSNSH RPELVRPALE RSLKNLQLDY VDLYLIHFPV
121 SVKPGEEVIP KDENGKILFD TVDLCATWEA MEKCKDAGLA KSIGVSNFNH RLLEMILNKP
181 GLKYKPVCNQ VECHPYFNQR KLLDFCKSKD IVLVAYSALG SHREEPWVDP NSPVLLEDPV
241 LCALAKKHKR TPALIALRYQ LQRGVVVLAK SYNEQRIRQN VQVFEFQLTS EEMKAIDGLN
301 RNVRYLTLDI FAGPPNYPFS DEYLocalizationUniProt · AlphaFold · HPA
Whether an antibody against AKR1C2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.23
- Highest tissue expression
- 449 nTPM
Expression across tissuesHPA
Tissue
- liver: 449 nTPM
- adipose tissue: 317 nTPM
- skeletal muscle: 270 nTPM
- urinary bladder: 234 nTPM
- breast: 196 nTPM
- esophagus: 192 nTPM
Single-cell type
- urothelial cells: 919 nCPM
- conjunctival goblet cells: 716 nCPM
- salivary duct cells: 704 nCPM
- hepatocytes: 562 nCPM
- foveolar cells: 333 nCPM
- ocular epithelial cells: 301 nCPM
Immune cell
- plasmacytoid DC: 0.1 nTPM
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
Brain region
- medulla oblongata: 30 nTPM
- pons: 27 nTPM
- hypothalamus: 27 nTPM
- thalamus: 25 nTPM
- midbrain: 19 nTPM
- spinal cord: 15 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about AKR1C2.
Disease | AllUniProt
Conditions AKR1C2 is implicated in, by any mechanism.
- 46,XY sex reversal 8 (SRXY8) MIM:614279
Disease | GeneticClinVar
5 pathogenic / likely-pathogenic of 121 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- 46,XY disorder of sex development due to testicular 17,20-desmolase deficiency
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.46
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.87
- DepMap mean gene effect
- 0.02
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cellular response to jasmonic acid stimulus
- cellular response to prostaglandin D stimulus
- daunorubicin metabolic process
- digestion
- doxorubicin metabolic process
- epithelial cell differentiation
- G protein-coupled receptor signaling pathway
- positive regulation of cell population proliferation
- positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction
- progesterone metabolic process
- prostaglandin metabolic process
- steroid metabolic process
Molecular functions
- 3-alpha-hydroxysteroid 3-dehydrogenase [NAD(P)+] activity
- aldose reductase (NADPH) activity
- androstan-3-alpha,17-beta-diol dehydrogenase (NAD+) activity
- androsterone dehydrogenase [NAD(P)+] activity
- bile acid binding
- carboxylic acid binding
- estradiol 17-beta-dehydrogenase [NAD(P)+] activity
- indanol dehydrogenase activity
- ketosteroid monooxygenase activity
- oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor
- trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of AKR1C2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads AKR1C2 as an antibody target. Whether an autoantibody or antibody against AKR1C2 could matter depends on whether native AKR1C2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
AKR1C2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label AKR1C2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...